Visiongain has published a new report on Automated Cannabis Testing Market Report until 2031. The market is segmented by type (terpenes profiling, residual solvents, heavy metals, pesticide screening, activity tests, microbial tests, genetic tests), by product and software (analytical instruments (analytical instruments). chromatography, gas chromatography, liquid chromatography, others, Spectroscopy instruments, mass spectroscopy, atomic spectroscopy, others), consumables (chromatography column, supplies and accessories, standards and CRMS, sample preparation products), software) , by end user (test laboratories, research institute, others). Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa). The report includes detailed profiles of the leading automated cannabis testing companies. PLUS COVID-19 recovery scenarios.
Download an exclusive sample report @ https://www.visiongain.com/report/automated-cannabis-testing-market/#download_sampe_div
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, price analysis , Gap Analysis, Forwarder 5 Force Model, Company Profiling, Geographic Analysis, and Analytical Market Overview. The increasing adoption of Laboratory Information Management System (LIMS) in cannabis testing labs and growing number of cannabis testing labs are some of the factors driving the growth of the Automated Testing Lab market. cannabis.
Impact of COVID-19 on the Global Automated Cannabis Testing Market
COVID-19 is a virulent new disease with increasing transmission and fatal outcome in the global population. The use of cannabidiol (CBD) for medical purposes is safe and effective for treating health problems. CBD has anti-inflammatory properties and has the ability to reduce pain and anxiety. Additionally, the combination of other cannabinoids and terpenes is important in clinical intervention and has the potential to treat symptoms of a virus such as COVID-19.
Market engine
Growing legalization for therapeutic and medical purposes.
The use of cannabis for therapeutic purposes (CTP) has recently become legal in various countries. However, legalization in various places allows for easy availability and a shift in perceptions of cannabis. The growing clinical evidence base for the use of cannabis therapies has combined social and political pressures to change regulatory frameworks to legalize cannabis use. The marijuana plant Cannabis sativa and its derivatives, cannabinoids, have significant therapeutic potential for inflammatory bowel disease (IBD). Cannabidiol is one of the natural cannabinoids found in cannabis. Cannabinoids are effective in treating epilepsy in various clinical trials. Epidiolex oral solution is a pure CBD product, has received US FDA approval for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome.
Growing adoption of Laboratory Information Management System (LIMS) in cannabis testing laboratories
The Laboratory Information Management System (LIMS) is a software tool for efficient data management and laboratory operation. It helps ensure regulatory compliance and delivers accurate and fast results. The Cannabis Testing Workflow provides a wide range of testing services which include terpene profiling, pesticide level screening, heavy metal and residual solvent testing.
Market opportunity
Growing recommendation to encourage improvisation in cannabis research.
The US Department of Health and Human Services, including the National Institutes of Health and the Centers for Disease Control and Prevention, should work together to jointly invest in R&D and ensure the implementation of guidelines for the production of high-quality research. quality on cannabis. Research programs must improve the benefits of acute and chronic use and reduce the harm associated with cannabis and cannabinoids.
Get the detailed table of contents @ https://www.visiongain.com/report/automated-cannabis-testing-market/#download_sampe_div
Competitive landscape
Agilent Technologies, Inc., Shimadzu Corporation, MCS, Inc., Restek Corporation, A&L Canada Laboratories Inc., Marrone Bio Innovations, Emerald Scientific LLC, PerkinElmer, Inc., Millipore Sigma, AB SCIEX LLC are some of the key contributors the growth of the global automated cannabis testing market. Market players are adopting new strategies to stay competitive in the global market, such as new product development, joint ventures, mergers and acquisitions, and geographic expansions.
For example, in August 2020, A&L Canada Laboratories Inc. announced the addition of the Hop Latent Viroid (HLVd) test to its cannabis disease diagnostic services. The company provides Plant Disease Diagnostics (PDD) for horticultural and greenhouse crops. The company offers comprehensive pest diagnostics and services to detect plant pathogens such as fungi, bacteria, viruses and nematodes, associated with plant tissues, soils, composts and water.
-
In October 2020, PerkinElmer, Inc. launched a fully automated liquid handling sample preparation and LC / MS / MS analysis workflow for pesticide residue testing on cannabis and flower samples. hemp. It offers cannabis-optimized reagents, sample preparation consumables, exclusive cannabis SOPs, and cloud-based tracking and reporting software.
-
In August 2020, Marrone Bio Innovations, Inc., an international leader in sustainable bioprotection and plant health solutions, entered into an agreement with Vive Crop Protection. The collaboration allows the company to combine organic with the Allosperse delivery system. The first product to emerge from this joint effort will be The AZterknot FC will be the company’s joint product, a fungicide for broad use in crops marketed by Vive Crop Protection.
Find quantitative and qualitative analyzes with independent predictions. Receive information that only our report contains, stay informed thanks to this valuable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Information found nowhere else
With our new report title, you’re less likely to fall behind in your knowledge or miss out on opportunities. See how our work could benefit your research, analysis and decisions. Visiongain’s study is aimed at anyone in need of business analysis for the automated cannabis testing market and large corporations. There you will find data, trends and forecasts.
Find more Visiongain research reports at Pharmaceutical diagnostics sector click on the following links:
Do you have custom requirements that we can help you with? Do you need specific information about a specific country, geographic region, market segment or company? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com
About Visiongain
Visiongain is one of the fastest growing and most innovative independent market intelligence, the company publishes hundreds of market research reports which it adds to its vast portfolio every year. These reports provide in-depth analysis of 18 industries around the world. The reports cover a 10-year forecast, are hundreds of pages long, with in-depth market analysis and valuable competitive intelligence data. Visiongain works across a range of verticals, which can currently influence each other, these markets include automotive, aviation, chemicals, cybersecurity, defense, energy, food and beverage, materials, packaging, pharmaceuticals and utilities. Our customized and syndicated market research reports mean you can have tailor-made market information tailored to your business needs.
Contact:
Catherine walker
Public Relations at Visiongain Inc.
Phone: + 44 0207 336 6100
United States Tel: +1 718 682 4567
EU Tel: + 353 1 695 0006
Toll free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Web: https://www.visiongain.com
Follow us: LinkedIn | Twitter
–
SOURCE Visiongain Limited.
Comments are closed.